Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jun 28;10(4):989-90.
doi: 10.1177/1932296815622647. Print 2016 Jul.

CSII: Longer Catheter Usage Time, a Reasonable Goal

Jean-Luc Ardilouze  1 , Julie Ménard  2 , Fernand Gobeil Jr  3 , Maude Gagnon-Auger  4 , Ghislaine Houde  5 , Marie-Hélène Pesant  5 , Rémi Rabasa-Lhoret  6 , Jean-Patrice Baillargeon  5
Affiliations
Comment

CSII: Longer Catheter Usage Time, a Reasonable Goal

Jean-Luc Ardilouze et al. J Diabetes Sci Technol. .
No abstract available

Keywords: CSII; adverse event; diabetes; insulin infusion set.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Comment in

Comment on

References

    1. Pfützner A, Sachsenheimer D, Grenningloh M, et al. Using insulin infusion sets in CSII for longer than the recommended usage time leads to a high risk for adverse events: results from a prospective randomized crossover study. J Diabetes Sci Technol. 2015;9(6):1292-1298. - PMC - PubMed
    1. Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2015;38:716-722. - PubMed
    1. Clausen TS, Kaastrup P, Stallknecht B. Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans. Diabetes Technol Ther. 2009;11:575-580. - PubMed
    1. Thethi TK, Rao A, Kawji H, et al. Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion. J Diabetes Complications. 2010;24:73-78. - PMC - PubMed
    1. Kerr D, Morton J, Whately-Smith C, Everett J, Begley JP. Laboratory-based non-clinical comparison of occlusion rates using three rapid-acting insulin analogs in continuous subcutaneous insulin infusion catheters using low flow rates. J Diabetes Sci Technol. 2008;2:450-455. - PMC - PubMed